10times
06 Sep 2021 • 

Implementing a Quality by Design QBD Approach In Integrated DSP In-Line PAT Advanced Analytical Technologies to Monitor Critical Quality Attributes.

AboutSpeakersExhibitorsReviewsPhotos

Official Links

Estimated Turnout

upto 100
Delegates

Editions

Sep 2021

Frequency

Newly Listed
Claim event to edit details

Dejan has spent the last ten years working for a biopharmaceutical company Lek d.d., a Novartis company. Currently he is working as a Principle .. Read more Scientist in Downstream Process Development Department. With a PhD degree in physics Dejan has a strong background in physical principles of protein association/aggregation, along with additional skills in mathematical modelling, statistical analysis and experimental biophysics. Dejan is currently responsible for new technology development and implementation in downstream processing. Majority of his work responsibilities is the nextBioPharmDSP project of EU Framework Program for Research and Innovation “Horizon 2020” for which the goal is to drive drug process development towards Continuous Processing in Biopharmaceutical Manufacturing. Dejan is leading new technology project of process analytical technology (PAT) as part of Quality by Design (QbD) approach implementation on integrated processes using Advanced Process Control (APC) control strategies, where APC control system is building.

  • Share your Experience
  • Organizer
LogoRequest a Booth

BIOPHARMA ASIA MAGAZINE

South Korea74 Total Events / 11 Upcoming Events

More Events From The Organizer

You have no contacts. Please add contacts from below or share on social media

Send to all
No Results